4.7 (130) In stock
By analysing secondary acute myeloid leukaemias, researchers at the Institute for Research in Biomedicine (IRB) Barcelona have detected mutations caused by platinum-based chemotherapies in cells that were healthy at the time of treatment.
Myelodysplastic Syndromes Treatment - NCI
Cancer and the cell cycle, Biology (article)
Synergistic immunotherapy targeting cancer-associated anemia
No shortage of biobank donors •
Chemotherapy - National Breast Cancer Foundation
Cancers, Free Full-Text
Frontiers Cancer chemotherapy: insights into cellular and tumor
Chemotherapy Statistics